Association of Gene Polymorphisms and Serum Levels of ALAS1 with the Risk of Anti‐Tuberculosis Drug‐Induced Liver Injury

Documenti analoghi

• Effects of FECH Gene Polymorphisms and Serum Ferrochelatase Levels on Antituberculosis Drug‐Induced Liver Injury in China
  di: Jingru Cheng, et al.
  Pubblicazione: (2025)
• Construction and Validation of a Predictive Model for the Risk of Anti‐Tuberculosis Drug‐Induced Liver Injury Based on Machine Learning Algorithms
  di: Jingru Cheng, et al.
  Pubblicazione: (2025)
• Changing Trajectories of Alanine Aminotransferase and Risk of Antituberculosis Drug‐Induced Liver Injury in Chinese Patients: A Cohort Study
  di: Xinyu Chen, et al.
  Pubblicazione: (2024)
• Review Article: Drug‐Induced Liver Injury Associated With Antibody‐Based Therapies in Haematologic Malignancies
  di: Mengmeng Lin, et al.
  Pubblicazione: (2025)
• Gut Microbiota in Patients with Tuberculosis Associated with Different Drug Exposures of Antituberculosis Drugs
  di: Yue Zhu, et al.
  Pubblicazione: (2025)